Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VNR in relapsed follicular, marginal zone, and mantle cell lymphoma
NCT01460602Phase 2Withdrawn
- Sponsor
- LSU Health Shreveport
- Start
- May 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), marginal zone lymphoma (MZL), mantle cell lymphoma (MCL), sponsored by LSU Health Shreveport. Planned start May 2010; status: withdrawn.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)marginal zone lymphoma (MZL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT01460602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460602.